Person · CIK 1236387

James N Wilson

Director at Corcept Therapeutics

Earlier: Amylin Pharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$9.4M

Noticed on Form 144$5.8M

Bought on Form 4$758K

Companies2

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Corcept Therapeutics CORT	Common Stock	By Trust	1,954,511	Dec 1, 2011 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	by James N. Wilson and Pamela D. Wilson Trust	1,588,094	Apr 19, 2004 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	James N. Wilson and Pamela D. Wilson Trust	1,054,543	Oct 15, 2026 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	By Family Partnership	901,067	Mar 20, 2015 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	James and Pamela Wilson Family Partners(	901,067	Dec 27, 2024 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	by James and Pamela Wilson Family Partners	606,060	Apr 19, 2004 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	James N. Wilson 2025 Grantor Retained Annuity Trust.	200,000	Apr 22, 2026 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	Pamela D. Wilson 2025 Grantor Retained Annuity Trust.	200,000	Apr 22, 2026 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	James N. Wilson 2025 Grantor Retained Annuity Trust	200,000	Oct 15, 2026 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	Pamela D. Wilson 2025 Grantor Retained Annuity Trust	200,000	Oct 15, 2026 · Filing · EDGAR
Corcept Therapeutics CORT	Stock Option (right to buy) exercise $59.69, expires May 21, 2036, into Common Stock	Directly	12,500	May 21, 2026 · Filing · EDGAR
Amylin Pharmaceuticals	Common Stock	by Trust-A	22,000	Aug 8, 2007 · Filing · EDGAR
Amylin Pharmaceuticals	Common Stock	by Partnership	3,500	Aug 7, 2007 · Filing · EDGAR
Amylin Pharmaceuticals	Common Stock	by Trust-B	2,000	Aug 7, 2007 · Filing · EDGAR
Amylin Pharmaceuticals	Common Stock	by Trust-C	2,000	Aug 7, 2007 · Filing · EDGAR
Amylin Pharmaceuticals	Phantom Stock-Deferred Compensation into Common Stock	Directly	15,695	Apr 3, 2009 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q4 2026	$1.1M	—	—
Q3 2026	$3.1M	$3.3M	—
Q2 2026	$832K	$2.5M	—
Q4 2016	$1.4M	Not machine-readable	—
Q1 2016	$6K	Not machine-readable	—
Q4 2015	$150K	Not machine-readable	—
Q3 2015	$159K	Not machine-readable	—
Q2 2015	$177K	Not machine-readable	—
Q1 2015	$49K	Not machine-readable	—
Q4 2011	$137K	Not machine-readable	—
Q3 2011	$155K	Not machine-readable	—
Q2 2011	$202K	Not machine-readable	—
Q1 2011	$175K	Not machine-readable	—
Q1 2009	—	—	$200K
Q1 2008	—	—	$98K
Q3 2007	$439K	Not machine-readable	$100K
Q2 2007	$220K	Not machine-readable	—
Q1 2007	—	—	$360K
Q3 2006	$375K	Not machine-readable	—
Q1 2006	$383K	Not machine-readable	—
Q4 2005	$320K	Not machine-readable	—

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Corcept Therapeutics CORT · Charles Schwab · 10b5-1 plan adopted Mar 17, 2026 · 2 notices
Sep 15, 2026	30,000 · ~$3.3M	Sep 15, 2026	Partly sold Sold 20,000 in 6 sales, Sep 15 to Oct 15 · $2.3M likely match Form 4 (1) · Form 4 (2)	Filing · EDGAR
Jun 16, 2026	30,000 · ~$2.5M	Jun 16, 2026	Sold as noticed Sold 30,000 in 9 sales, Jun 16 to Aug 14 · $2.8M Form 4 (1) · Form 4 (2) · Form 4 (3)	Filing · EDGAR
Sales without a matching Form 144 · 58 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 14,216 at $9.10 on Nov 11, 2016 · $129K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 33,247 at $8.90 on Nov 10, 2016 · $296K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 111,349 at $8.32 on Nov 9, 2016 · $927K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 0 on Jan 6, 2016	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 1,188 at $4.90 on Jan 6, 2016 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 0 on Dec 1, 2015	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $5.20 on Dec 1, 2015 · $52K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 0 on Nov 12, 2015	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 20,000 at $4.90 on Nov 12, 2015 · $98K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 0 on Sep 1, 2015	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $4.90 on Sep 1, 2015 · $49K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 0 on Aug 5, 2015	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 4,100 at $4.90 on Aug 5, 2015 · $20K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 2,900 at $4.90 on Aug 4, 2015 · $14K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 3,000 at $4.97 on Aug 3, 2015 · $15K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 0 on Jul 1, 2015	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $6.06 on Jul 1, 2015 · $61K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $6.13 on Jun 2, 2015 · $61K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $5.92 on May 4, 2015 · $59K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $5.60 on Apr 1, 2015 · $56K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 8,359 at $5.85 on Mar 20, 2015 · $49K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $3.08 on Dec 1, 2011 · $15K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $3.09 on Dec 1, 2011 · $31K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $3.03 on Nov 1, 2011 · $15K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $3.06 on Nov 1, 2011 · $31K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $3.00 on Oct 5, 2011 · $15K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $3.01 on Oct 3, 2011 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $3.01 on Sep 7, 2011 · $15K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $3.00 on Sep 7, 2011 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $3.41 on Aug 1, 2011 · $17K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $3.47 on Aug 1, 2011 · $35K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $3.90 on Jul 1, 2011 · $20K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $3.90 on Jul 1, 2011 · $39K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $4.90 on Jun 1, 2011 · $25K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $4.90 on Jun 1, 2011 · $49K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $4.33 on May 2, 2011 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $4.31 on May 2, 2011 · $43K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $4.25 on Apr 1, 2011 · $21K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $4.25 on Apr 1, 2011 · $43K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $3.77 on Mar 1, 2011 · $19K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $3.78 on Mar 1, 2011 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $4.10 on Feb 1, 2011 · $21K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $4.09 on Feb 1, 2011 · $41K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $3.82 on Jan 3, 2011 · $19K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 10,000 at $3.82 on Jan 3, 2011 · $38K	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 3,334 at $51.44 on Aug 8, 2007 · $172K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 3,334 at $50.18 on Aug 7, 2007 · $167K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 2,000 at $50.03 on Aug 7, 2007 · $100K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 1,666 at $46.24 on May 31, 2007 · $77K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 500 at $46.24 on May 31, 2007 · $23K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 500 at $45.52 on May 22, 2007 · $23K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 1,666 at $44.80 on May 21, 2007 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 500 at $44.80 on May 21, 2007 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 7,000 at $50.00 on Jul 10, 2006 · $350K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 500 at $50.00 on Jul 10, 2006 · $25K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 8,000 at $45.08 on Jan 27, 2006 · $361K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 500 at $45.08 on Jan 27, 2006 · $23K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Amylin Pharmaceuticals: Sold 8,000 at $40.00 on Dec 20, 2005 · $320K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Corcept Therapeutics CORT Director · filings 2004 to 2026 · sold $7.6M · bought $758K · $5.8M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 15, 2026	Sale under a 10b5-1 plan	−6,654	$114.48	$762K	1,057,889 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Oct 15, 2026	Sale under a 10b5-1 plan	−3,046	$115.39	$351K	1,054,843 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Oct 15, 2026	Sale under a 10b5-1 plan	−300	$116.30	$35K	1,054,543 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Sep 15, 2026	Sale under a 10b5-1 plan	−6,800	$110.27	$750K	1,067,743 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Sep 15, 2026	Sale under a 10b5-1 plan	−400	$110.84	$44K	1,067,343 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Sep 15, 2026	Sale under a 10b5-1 plan	−2,800	$111.70	$313K	1,064,543 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Aug 14, 2026	Sale under a 10b5-1 plan	−3,053	$110.49	$337K	1,081,490 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Aug 14, 2026	Sale under a 10b5-1 plan	−4,668	$111.44	$520K	1,076,822 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Aug 14, 2026	Sale under a 10b5-1 plan	−2,279	$112.64	$257K	1,074,543 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jul 15, 2026	Sale under a 10b5-1 plan	−1,079	$86.78	$94K	1,093,464 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jul 15, 2026	Sale under a 10b5-1 plan	−3,969	$87.74	$348K	1,089,495 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jul 15, 2026	Sale under a 10b5-1 plan	−2,974	$88.81	$264K	1,086,521 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jul 15, 2026	Sale under a 10b5-1 plan	−1,978	$89.49	$177K	1,084,543 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jun 16, 2026	Sale under a 10b5-1 plan	−4,177	$82.69	$345K	1,100,366 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jun 16, 2026	Sale under a 10b5-1 plan	−5,823	$83.57	$487K	1,094,543 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
May 27, 2026	Gift	−892,056			9,011 James and Pamela Wilson Family Partners	Filing · EDGAR
May 27, 2026	Gift	−9,011			0 James and Pamela Wilson Family Partners	Filing · EDGAR
May 27, 2026	Gift	+9,011			1,104,543 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
May 21, 2026	Grant or award from the company Stock Option (right to buy)	+12,500			12,500 direct	Filing · EDGAR
Apr 22, 2026	Gift	−2,000			1,095,532 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Apr 6, 2026	Gift	−5,000			1,097,532 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Mar 20, 2026	Gift	−4,000			1,102,532 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Mar 13, 2026	Gift	−28,000			1,106,532 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Feb 24, 2026	Option or RSU exercised or converted	+100,000	$3.88	$388K	100,000 direct	Filing · EDGAR
Feb 24, 2026	Shares withheld for tax or exercise price	−10,636	$36.48	$388K	89,364 direct	Filing · EDGAR
Feb 24, 2026	Gift	−89,364			0 direct	Filing · EDGAR
Feb 24, 2026	Other acquisition or disposition (see the filing)	+89,364			1,134,532 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Feb 24, 2026	Option or RSU exercised or converted Stock option (right to buy)	+100,000			0 direct	Filing · EDGAR
Dec 12, 2025	Gift	−400,000			1,045,168 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Dec 12, 2025	Other acquisition or disposition (see the filing)	+200,000			200,000 James N. Wilson 2025 Grantor Retained Annuity Trust.	Filing · EDGAR
Dec 12, 2025	Other acquisition or disposition (see the filing)	+200,000			200,000 Pamela D. Wilson 2025 Grantor Retained Annuity Trust.	Filing · EDGAR
Jun 10, 2025	Grant or award from the company Stock option (right to buy)	+25,000			25,000 direct	Filing · EDGAR
Jan 27, 2025	Gift	−7,800			1,445,168 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jan 22, 2025	Option or RSU exercised or converted	+250,000	$3.29	$823K	250,000 direct	Filing · EDGAR
Jan 22, 2025	Shares withheld for tax or exercise price	−103,258	$59.03	$6.1M	146,742 direct	Filing · EDGAR
Jan 22, 2025	Gift	−146,742			0 direct	Filing · EDGAR
Jan 22, 2025	Other acquisition or disposition (see the filing)	+146,742			1,452,968 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jan 22, 2025	Option or RSU exercised or converted Stock option (right to buy)	−250,000			0 direct	Filing · EDGAR
Dec 27, 2024	Gift	−7,800			1,306,226 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
May 23, 2024	Gift	−2,000			1,314,026 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
May 17, 2024	Grant or award from the company Employee stock option (right to buy)	+80,000			80,000 direct	Filing · EDGAR
Nov 13, 2023	Gift	−3,000			1,316,026 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
May 19, 2023	Grant or award from the company Stock option (right to buy)	+80,000			80,000 direct	Filing · EDGAR
Jun 14, 2022	Option or RSU exercised or converted	+300,000	$2.08	$624K	300,000 direct	Filing · EDGAR
Jun 14, 2022	Shares withheld for tax or exercise price	−131,819	$21.10	$2.8M	168,181 direct	Filing · EDGAR
Jun 14, 2022	Other acquisition or disposition (see the filing)	−168,181			168,181 direct	Filing · EDGAR
Jun 14, 2022	Other acquisition or disposition (see the filing)	+168,181			1,331,026 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jun 14, 2022	Option or RSU exercised or converted Stock option (right to buy)	+300,000			0 direct	Filing · EDGAR
May 31, 2022	Grant or award from the company Stock option (right to buy)	+45,000			90,000 direct	Filing · EDGAR
Feb 2, 2022	Gift	−12,000			1,319,026 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
May 26, 2021	Grant or award from the company Stock Option (Right to Buy)	+45,000			45,000 direct	Filing · EDGAR
Apr 14, 2021	Option or RSU exercised or converted	+200,000	$4.42	$884K	200,000 direct	Filing · EDGAR
Apr 14, 2021	Shares withheld for tax or exercise price	−90,517	$22.95	$2.1M	109,483 direct	Filing · EDGAR
Apr 14, 2021	Other acquisition or disposition (see the filing)	−109,483			0 direct	Filing · EDGAR
Apr 14, 2021	Other acquisition or disposition (see the filing)	+109,483			1,174,845 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Apr 14, 2021	Option or RSU exercised or converted Stock Option (Right to Buy)	−200,000			0 direct	Filing · EDGAR
Jan 21, 2021	Gift	−12,000			1,162,845 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Nov 19, 2020	Gift	−253,712			1,065,362 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
Jul 10, 2020	Gift	−12,500			1,319,074 James N. Wilson and Pamela D. Wilson Trust	Filing · EDGAR
May 27, 2020	Grant or award from the company Stock Option (Right to Buy)	+80,000			80,000 direct	Filing · EDGAR

117 earlier transactions are in the filing list below.

Amylin Pharmaceuticals Director · filings 2003 to 2009 · sold $1.7M

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 3, 2009	Grant or award from the company Phantom Stock-Deferred Compensation	+4,404	$9.51	$42K	15,695 direct	Filing · EDGAR
Jan 13, 2009	Grant or award from the company Phantom Stock-Deferred Compensation	+1,663	$11.64	$19K	11,291 direct	Filing · EDGAR
Oct 3, 2008	Grant or award from the company Phantom Stock-Deferred Compensation	+1,013	$19.12	$19K	9,628 direct	Filing · EDGAR
Jul 2, 2008	Grant or award from the company Phantom Stock-Deferred Compensation	+739	$26.22	$19K	8,615 direct	Filing · EDGAR
May 30, 2008	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Apr 2, 2008	Grant or award from the company Phantom Stock-Deferred Compensation	+605	$32.03	$19K	7,876 direct	Filing · EDGAR
Jan 10, 2008	Grant or award from the company Phantom Stock-Deferred Compensation	+549	$35.25	$19K	7,271 direct	Filing · EDGAR
Oct 4, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+388	$49.92	$19K	6,722 direct	Filing · EDGAR
Aug 8, 2007	Sale under a 10b5-1 plan	−3,334	$51.44	$172K	22,000 by Trust-A	Filing · EDGAR
Aug 7, 2007	Sale under a 10b5-1 plan	−2,000	$50.03	$100K	3,500 by Partnership	Filing · EDGAR
Aug 7, 2007	Sale under a 10b5-1 plan	−3,334	$50.18	$167K	25,334 by Trust-A	Filing · EDGAR
Jul 6, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+460	$42.05	$19K	6,334 direct	Filing · EDGAR
May 31, 2007	Sale under a 10b5-1 plan	−500	$46.24	$23K	5,500 by Partnership	Filing · EDGAR
May 31, 2007	Sale under a 10b5-1 plan	−1,666	$46.24	$77K	28,668 by Trust-A	Filing · EDGAR
May 23, 2007	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
May 22, 2007	Sale under a 10b5-1 plan	−500	$45.52	$23K	6,000 by Partnership	Filing · EDGAR
May 21, 2007	Sale under a 10b5-1 plan	−500	$44.80	$22K	6,500 by Partnership	Filing · EDGAR
May 21, 2007	Sale under a 10b5-1 plan	−1,666	$44.80	$75K	30,334 by Trust-A	Filing · EDGAR
Apr 3, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+511	$37.86	$19K	5,874 direct	Filing · EDGAR
Feb 23, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+231	$40.48	$9K	5,363 direct	Filing · EDGAR
Jan 12, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+249	$40.11	$10K	5,132 direct	Filing · EDGAR
Oct 5, 2006	Grant or award from the company Phantom Stock-Deferred Compensation	+228	$43.74	$10K	4,883 direct	Filing · EDGAR
Jul 13, 2006	Grant or award from the company Phantom Stock-Deferred Compensation	+202	$49.44	$10K	4,655 direct	Filing · EDGAR
Jul 10, 2006	Sale under a 10b5-1 plan	−500	$50.00	$25K	7,000 by Partnership	Filing · EDGAR
Jul 10, 2006	Sale under a 10b5-1 plan	−7,000	$50.00	$350K	32,000 by Trust-A	Filing · EDGAR
May 17, 2006	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Apr 5, 2006	Grant or award from the company Phantom Stock-Deferred Compensation	+216	$46.16	$10K	4,453 direct	Filing · EDGAR
Jan 27, 2006	Sale under a 10b5-1 plan	−500	$45.08	$23K	7,500 by Partnership	Filing · EDGAR
Jan 27, 2006	Sale under a 10b5-1 plan	−8,000	$45.08	$361K	39,000 by Trust-A	Filing · EDGAR
Jan 5, 2006	Grant or award from the company Phantom Stock-Deferred Compensation	+248	$40.25	$10K	4,237 direct	Filing · EDGAR
Dec 20, 2005	Sale under a 10b5-1 plan	−8,000	$40.00	$320K	47,000 by Trust-A	Filing · EDGAR
Oct 4, 2005	Grant or award from the company Phantom Stock-Deferred Compensation	+265	$37.70	$10K	3,989 direct	Filing · EDGAR
Jul 1, 2005	Grant or award from the company Phantom Stock-Deferred Compensation	+300	$21.12	$6K	3,564 direct	Filing · EDGAR
Jul 1, 2005	Grant or award from the company Phantom Stock-Deferred Compensation	+160	$21.14	$3K	3,724 direct	Filing · EDGAR
May 25, 2005	Other acquisition or disposition (see the filing) Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Apr 4, 2005	Grant or award from the company Phantom Stock-Deferred Compensation	+555	$17.32	$10K	3,264 direct	Filing · EDGAR
Dec 30, 2004	Grant or award from the company Phantom Stock-Deferred Compensation	+100	$23.62	$2K	2,494 direct	Filing · EDGAR
Dec 30, 2004	Grant or award from the company Phantom Stock-Deferred Compensation	+215	$23.60	$5K	2,709 direct	Filing · EDGAR
Nov 23, 2004	Grant or award from the company Phantom Stock-Deferred Compensation	+100	$23.52	$2K	2,394 direct	Filing · EDGAR
Oct 1, 2004	Grant or award from the company Phantom Stock-Deferred Compensation	+470	$21.05	$10K	2,294 direct	Filing · EDGAR
Jul 6, 2004	Grant or award from the company Phantom Stock-Deferred Compensation	+435	$22.41	$10K	1,824 direct	Filing · EDGAR
May 5, 2004	Other acquisition or disposition (see the filing) Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Apr 1, 2004	Grant or award from the company Phantom Stock-Deferred Compensation	+410	$23.57	$10K	1,389 direct	Filing · EDGAR
Jan 12, 2004	Grant or award from the company Phantom Stock-Deferred Compensation	+350	$22.02	$8K	979 direct	Filing · EDGAR
Oct 16, 2003	Grant or award from the company Phantom Stock-Deferred Compensation	+275	$28.53	$8K	629 direct	Filing · EDGAR
Jul 8, 2003	Grant or award from the company Phantom Stock-Deferred Compensation	+354	$22.52	$8K	354 direct	Filing · EDGAR
Apr 1, 2003	Grant or award from the company Phantom Stock Units	+506	$15.85	$8K	1,492 direct	Filing · EDGAR
Jan 1, 2003	Grant or award from the company Phantom Stock Units	+285	$16.65	$5K	986 direct	Filing · EDGAR
Oct 1, 2002	Grant or award from the company Phantom Stock Units	+75	$16.64	$1K	701 direct	Filing · EDGAR
Jul 1, 2002	Grant or award from the company Phantom Stock Units	+156	$9.60	$1K	416 direct	Filing · EDGAR
Apr 1, 2002	Grant or award from the company Phantom Stock Units	+244	$10.25	$3K	244 direct	Filing · EDGAR

All 120 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Oct 16, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Sep 16, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Sep 15, 2026	Form 144	Corcept Therapeutics CORT	Filing · EDGAR
Aug 18, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 17, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 18, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 16, 2026	Form 144	Corcept Therapeutics CORT	Filing · EDGAR
May 29, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 26, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 24, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 8, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 24, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 17, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Feb 26, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Dec 16, 2025	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 12, 2025	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jan 29, 2025	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jan 24, 2025	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Dec 31, 2024	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 28, 2024	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 21, 2024	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Nov 15, 2023	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 23, 2023	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Feb 14, 2023	Form 5	Corcept Therapeutics CORT	Filing · EDGAR
Jun 16, 2022	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 2, 2022	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 28, 2021	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 16, 2021	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Feb 11, 2021	Form 5	Corcept Therapeutics CORT	Filing · EDGAR
Jul 17, 2020	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 17, 2020	Form 4/A	Corcept Therapeutics CORT	Filing · EDGAR
May 29, 2020	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Oct 30, 2019	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 20, 2019	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 11, 2019	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 7, 2019	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 22, 2018	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 2, 2018	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 10, 2018	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 26, 2017	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 7, 2017	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 2, 2017	Form 5/A	Corcept Therapeutics CORT	Filing · EDGAR
Mar 2, 2017	Form 4/A	Corcept Therapeutics CORT	Filing · EDGAR
Feb 14, 2017	Form 5	Corcept Therapeutics CORT	Filing · EDGAR
Nov 14, 2016	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 20, 2016	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jan 6, 2016	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Dec 3, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Nov 12, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Sep 3, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 5, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 6, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 3, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 11, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 3, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 24, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Feb 23, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Feb 13, 2015	Form 5	Corcept Therapeutics CORT	Filing · EDGAR
Feb 1, 2013	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Dec 1, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Nov 2, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Oct 5, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Sep 7, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 1, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 6, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 2, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 23, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 3, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 5, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 3, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Feb 1, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jan 5, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Dec 7, 2009	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 7, 2009	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Feb 12, 2009	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jan 15, 2009	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Nov 13, 2008	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Oct 6, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jul 7, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 30, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Apr 4, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Mar 27, 2008	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jan 14, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Oct 9, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Aug 20, 2007	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 8, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jul 10, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jun 1, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 24, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 23, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 22, 2007	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 5, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Apr 3, 2007	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 2, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jan 17, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Dec 19, 2006	Form 4/A	Corcept Therapeutics CORT	Filing · EDGAR
Dec 18, 2006	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Oct 11, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jul 26, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jul 12, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 19, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 8, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Mar 7, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Feb 14, 2006	Form 5	Amylin Pharmaceuticals	Filing · EDGAR
Jan 27, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Dec 20, 2005	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jul 6, 2005	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 26, 2005	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Apr 5, 2005	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jan 3, 2005	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Oct 4, 2004	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jul 12, 2004	Form 4/A	Amylin Pharmaceuticals	Filing · EDGAR
Jul 7, 2004	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 6, 2004	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Apr 21, 2004	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 14, 2004	Form 3	Corcept Therapeutics CORT	Filing · EDGAR
Apr 2, 2004	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jan 12, 2004	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Oct 17, 2003	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Aug 27, 2003	Form 4	Amylin Pharmaceuticals	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 1:47 AM ET. The filing on SEC.gov is the record.